Immunosuppressant Indulges EBV Reactivation and Related Lymphoproliferative Disease by Inhibiting Vδ2+ T Cells Activities After Hematopoietic Transplantation for Blood Malignancies

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1136/jitc-2019-000208

Related search